These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8548946)

  • 21. Gonadotropin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
    Gregoriou O; Konidaris S; Vitoratos N; Papadias C; Papoulias I; Chryssicopoulos A
    Int J Fertil Womens Med; 1997; 42(6):406-11. PubMed ID: 9459084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients.
    Matikainen T; Haavisto AM; Permi J; de Kretser D; Huhtaniemi I
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):743-50. PubMed ID: 8033364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in gonadotrophin response to gonadotrophin releasing hormone in normal women following bilateral ovariectomy.
    Alexandris E; Milingos S; Kollios G; Seferiadis K; Lolis D; Messinis IE
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):721-6. PubMed ID: 9497880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropin-releasing hormone agonist plus "add-back" hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial.
    Franke HR; van de Weijer PH; Pennings TM; van der Mooren MJ
    Fertil Steril; 2000 Sep; 74(3):534-9. PubMed ID: 10973651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women.
    Wide L; Naessén T; Eriksson K; Rune C
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):651-8. PubMed ID: 8759177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis.
    Rannevik G
    Postgrad Med J; 1979; 55 Suppl 5():14-20. PubMed ID: 537948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
    Cedars MI; Lu JK; Meldrum DR; Judd HL
    Obstet Gynecol; 1990 Apr; 75(4):641-5. PubMed ID: 2138265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of gonadotrophins with differing LH/FSH ratios on the secretion of the various species of inhibin in women receiving IVF.
    Fawzy M; Harrison RF; Knight PG; Groome N; Anderson A; Robertson WR; Lambert A
    Hum Reprod; 2001 Jun; 16(6):1092-7. PubMed ID: 11387274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women.
    Robertson JF; Blamey RW
    Eur J Cancer; 2003 May; 39(7):861-9. PubMed ID: 12706354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of inhibin and oestradiol in the control of FSH secretion in the sheep.
    Mann GE; Campbell BK; McNeilly AS; Baird DT
    J Endocrinol; 1992 Jun; 133(3):381-91. PubMed ID: 1613439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
    Richardson DW; Gordon K; Billiar RB; Little AB
    Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
    Anderson RA; Groome NP; Baird DT
    Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FSH inhibits the augmentation by oestradiol of the pituitary responsiveness to GnRH in the female rat.
    Schuiling GA; Valkhof N; Koiter TR
    Hum Reprod; 1999 Jan; 14(1):21-6. PubMed ID: 10374088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibin B in males with gonadotropin-releasing hormone (GnRH) deficiency: changes in serum concentration after shortterm physiologic GnRH replacement--a clinical research center study.
    Seminara SB; Boepple PA; Nachtigall LB; Pralong FP; Khoury RH; Sluss PM; Lecain AE; Crowley WF
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3692-6. PubMed ID: 8855824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between inhibin, oestradiol and progesterone in the control of gonadotrophin secretion in the ewe.
    Martin GB; Price CA; Thiéry JC; Webb R
    J Reprod Fertil; 1988 Jan; 82(1):319-28. PubMed ID: 3123665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of the effectiveness of gonadotrophin-releasing hormone, steroids and follicular fluid in modulating ovine gonadotrophin output in vivo and in vitro.
    Henderson KM; Ellen RL; Savage LC; McNatty KP
    J Reprod Fertil; 1989 May; 86(1):105-17. PubMed ID: 2502617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does a positive oestrogen feedback on the hypothalamic-pituitary axis exist concurrently with a defective testosterone feedback in Klinefelter's syndrome?
    Goh VH; Lee KO
    Horm Res; 1998 Sep; 50(3):160-5. PubMed ID: 9762005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The depot GnRH analogue goserelin in the treatment of premenopausal patients with metastatic breast cancer--a 5-year experience and further endocrine therapies. Cooperative German Zoladex Study Group.
    Kaufmann M; Jonat W; Schachner-Wünschmann E; Bastert G; Maass H
    Onkologie; 1991 Feb; 14(1):22-4, 26-8, 30. PubMed ID: 1829149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism.
    Tiitinen A; Simberg N; Stenman UH; Ylikorkala O
    J Clin Endocrinol Metab; 1994 Aug; 79(2):447-51. PubMed ID: 8045961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic-pituitary-gonadal axis in two men with aromatase deficiency: evidence that circulating estrogens are required at the hypothalamic level for the integrity of gonadotropin negative feedback.
    Rochira V; Zirilli L; Genazzani AD; Balestrieri A; Aranda C; Fabre B; Antunez P; Diazzi C; Carani C; Maffei L
    Eur J Endocrinol; 2006 Oct; 155(4):513-22. PubMed ID: 16990650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.